Alembic Pharmaceuticals

From Vedanta, Adani Power to RailTel, Aditya Birla Capital – Here are 11 stocks to watch today

Track key stocks like Vedanta, Adani Power, RailTel, and Aditya Birla Capital as major announcements drive market action today—see the…

September 15, 2025 06:30 IST

Q3FY25: Alembic Pharma’s profit dips 23.29 percent to Rs 138.42 crore

The company posted revenue from operations at Rs 1,692.74 crore, up 3.81 per cent as against Rs 1,630.57 crore during…

February 3, 2025 15:50 IST

USFDA gives nod to Alembic Pharma’s anti-epileptic drug

Alembic has a cumulative total of 220 ANDA approvals (193 final approvals and 27 tentative approvals) from USFDA.

December 20, 2024 14:13 IST

USFDA gives nod to Alembic Pharma’s generic formulation to treat itchy eyes

Alembic has a cumulative total of 219 ANDA approvals (192 final approvals and 27 tentative approvals) from USFDA.

December 4, 2024 13:47 IST

USFDA gives nod to Alembic Pharma for its generic formulation to treat hypertension

Alembic has a cumulative total of 218 ANDA approvals (191 final approvals and 27 tentative approvals) from USFDA, it added.

November 11, 2024 13:08 IST

USFDA gives nod to Alembic Pharma’s generic formulation to treat heart disorder

Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2…

October 21, 2024 11:25 IST

USFDA gives nod to Alembic Pharma’s generic formulation to treat itchy eyes

Alembic has a cumulative total of 216 ANDA approvals (189 final approvals and 27 tentative approvals) from USFDA.

October 4, 2024 14:25 IST

USDA gives nod to Alembic Pharma’s generic formulation to treat seizures

Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.

October 3, 2024 14:17 IST

Alembic Pharma, Alembic Pharma q1fy25, q1fy25 news, Alembic Pharma news, healthcare news, pharma news,

Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent

Alembic Q1 Results: According to the company’s statement, India Branded Business grew 9 percent to Rs. 572 crores for the…

August 8, 2024 15:01 IST

Alembic Pharma, USFDA, generic formulations, ANDA approval, Leukemia, healthcare news, pharma news,

USFDA gives nod to Alembic Pharma’s generic formulation to treat leukemia

Nelarabine Injection, 250 mg/50 mL has an estimated market size of US$ 23 million for twelve months ending March 2024…

August 2, 2024 12:27 IST

USFDA gives nod to Alembic Pharma’s generic formulation to treat high blood pressure in lungs

Alembic has a cumulative total of 208 ANDA approvals (180 final approvals and 28 tentative approvals) from USFDA, it stated.

July 15, 2024 16:17 IST

USFDA gives nod to Alembic Pharmaceuticals’ generic formulation to prevent stroke

Dabigatran Etexilate Capsules 75 mg and 150 mg have an estimated market size of US$ 179 million for twelve months…

June 18, 2024 17:08 IST

Alembic Pharmaceuticals, Alembic Pharma, USFDA, USFDA nod, healthcare news, pharma news,

Alembic Pharma gets USFDA nod for its injection to treat rare genetic condition

Alembic has a cumulative total of 205 ANDA approvals (177 final approvals and 28 tentative approvals) from USFDA.

June 17, 2024 15:30 IST

Alembic Pharmaceuticals gets USFDA nod to its generic formulation to treat heart failure

Sacubitril and Valsartan Tablets have an estimated market size of US$ 5.3 billion for twelve months ending March 2024 according…

May 30, 2024 16:56 IST

Alembic Pharmaceuticals gets EIR for its Oncology Formulation Facility in Gujarat

With this latest development, Alembic Pharmaceuticals Limited holds EIRs for all its US FDA-regulated facilities, the company stated.

May 6, 2024 15:46 IST

Alembic Pharmaceuticals, Alembic Pharma Q3 results, quarter earnings, profit, revenue, EBITDA, Pharmaceuticals industry

Alembic Pharmaceuticals appoints Manish Kejriwal as Independent Director

Prior to founding Kedaara Capital, Kejriwal served as the head of the India office of Temasek Holdings Pte. Ltd., managing…

April 2, 2024 11:51 IST

USFDA gives nod to Alembic Pharma’s breast cancer drug

It is the generic equivalent of Novartis’ Kisqali tablets.

April 1, 2024 14:21 IST

Alembic Pharmaceuticals Q3 Results: Profit up 48% at Rs 180.45 crore, revenue rises 8.1% on-year

Alembic Pharmaceuticals posted revenue from operations at Rs 1,630.57 crore, up 8.1 per cent as against Rs 1,509.02 crore during…

February 5, 2024 14:51 IST

Related News

Facing H-1B green card hurdles, Canada-based manager chooses India Over US for career growth

Canada-based manager rejects US move due to H-1B and green card process, considers India, says ‘I don’t want my career to…’

H-1B $100,000 fee explained: Not annual, not for current techies in US – 8 myths busted

H-1B visa program, foreign workers, OPT programs, H-1B visa lottery, US Jobs

H-1B visa bill introduced to scrap lottery, end OPT program for foreign workers

The high cost of "Easy" EMIs: Why Warren Buffett's advice is more important than ever.

Warren Buffett’s warning for India’s EMI generation

How many Indians earn more than Rs 1 crore annually? The Hurun Wealth Report 2025 reveals

Retailers get ready for bumper sales this festive season

Business4 hr ago

E-commerce sales during festive season to hit Rs 1.15 lakh crore, up 20-25% from last year. Quick commerce up 150%, value commerce up 30-35%. Festive sales may contribute 40% of annual turnover for retailers in consumer electronics and jewellery. E-commerce platforms offering discounts and strengthening supply chains. Offline retailers also optimistic.

View all shorts